Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies

S. Baldari, G. Di Rocco, M. Piccoli, M. Pozzobon, M. Muraca, G. Toietta

Research output: Contribution to journalArticlepeer-review


Cell-based therapies have the potential to revolutionize current treatments for diseases with high prevalence and related economic and social burden. Unfortunately, clinical trials have made only modest improvements in restoring normal function to degenerating tissues. This limitation is due, at least in part, to the death of transplanted cells within a few hours after transplant due to a combination of mechanical, cellular, and host factors. In particular, mechanical stress during implantation, extracellular matrix loss upon delivery, nutrient and oxygen deprivation at the recipient site, and host inflammatory response are detrimental factors limiting long-term transplanted cell survival. The beneficial effect of cell therapy for regenerative medicine ultimately depends on the number of administered cells reaching the target tissue, their viability, and their promotion of tissue regeneration. Therefore, strategies aiming at improving viable cell engraftment are crucial for regenerative medicine. Here we review the major factors that hamper successful cell engraftment and the strategies that have been studied to enhance the beneficial effects of cell therapy. Moreover, we provide a perspective on whether mesenchymal stromal cell-derived extracellular vesicle delivery, as a cell-free regenerative approach, may circumvent current cell therapy limitations.
Original languageEnglish
Pages (from-to)E2087
JournalInternational Journal of Molecular Sciences
Issue number10
Publication statusPublished - Oct 2 2017


  • anoikis
  • cell survival
  • cell therapy
  • cell transplantation
  • extracellular vesicles
  • hypoxia
  • mesenchymal stromal cells
  • regenerative medicine


Dive into the research topics of 'Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies'. Together they form a unique fingerprint.

Cite this